MAPT and Alzheimer disease: Several mechanisms contribute to synapse dysfunction in AD, including amyloid beta peptide (Aβ) and tau protein [14], synaptic pruning [15, 16], inflammatory processes [17], mitochondrial dysfunction, and cholinergic signaling, particularly acetylcholinesterase [18–21] (Fig. 1).